Status | Study |
Completed |
Study Name: A Study of Evacetrapib (LY2484595) in Participants With Hepatic (Liver) Impairment Condition: Hepatic Insufficiency Date: 2013-04-17 Interventions: Drug: Evacetrapib Other Name: LY2484595 |
Completed |
Study Name: The Influence of Hepatic Insufficiency on the Pharmacokinetics of Elbasvir (MK-8742) (MK-8742-009) Condition: Hepatic Insufficiency Date: 2013-02-20 Interventions: Drug: Elbasvir |
Completed |
Study Name: Evaluate the Pharmacokinetics, Safety, and Tolerability of Alisporivir in Subjects With Hepatic Impairment Compared to Healthy Subjects Condition: Hepatic Insufficiency Date: 2012-02-21 Interventions: Drug: Alisporivir Capsules supplied as open labeled bulk medication in 10-unit blister packages |
Completed |
Study Name: Assessment of Pharmacokinetics of Single Dose Odanacatib (MK-0822) in Subjects With Moderate Hepatic Insufficiency (MK-0822-070) Condition: Hepatic Insufficiency Date: 2012-01-13 Interventions: Drug: Single Dose MK-0822 A one-time, single-dose (50 mg tablet) administered orally on Day 1 |
Completed |
Study Name: A Study of LY2140023 in Hepatic Impaired Participants Condition: Hepatic Insufficiency Date: 2011-11-16 Interventions: Drug: LY2140023 Administered orally |
Completed |
Study Name: Pharmacokinetics of 9-cis-retinoic Acid (Alitretinoin, Toctino®) in Patients With Hepatic Disease Condition: Hepatic Insufficiency Date: 2010-12-15 Interventions: Drug: Alitretinoin 30 mg capsule of 9-cis-retinoic-acid (9-cis-RA)(Alitretinoin, Toctino®) |
Completed |
Study Name: Pharmacokinetics of Anacetrapib (MK0859) in Patients With Hepatic Insufficiency (MK-0859-039) Condition: Dyslipidemia Date: 2010-04-29 Interventions: Drug: anacetrapib single dose administration of anacetrapib (MK0859) 100 mg oral tablet |
Completed |
Study Name: Pharmacokinetics of Suvorexant in Participants With Hepatic Insufficiency (MK-4305-017) Condition: Insomnia Hepatic Insufficiency Date: 2010-01-05 Interventions: Drug: Suvorexant single 20 mg dose of suvorexant will be administered as 2 x 10 mg film coated tablets o |
Completed |
Study Name: Ridaforolimus in Patients With Hepatic Insufficiency (MK-8669-046) Condition: Healthy Volunteers Hepatic Insufficiency Date: 2010-01-05 Interventions: Drug: ridaforolimus single oral dose administration 10 mg ridaforolimus |
Completed |
Study Name: Hepatic Impaired Subjects Compared to Healthy Subjects Receiving Multi-dose BMS-650032 Condition: Hepatic Insufficiency Date: 2009-11-24 Interventions: Drug: BMS-650032 Capsules, Oral, 200 mg, BID, 7 Days |